Seres Therapeutics, Inc.
MCRB- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001609809
In the last 90 days, Seres Therapeutics, Inc. insiders filed 0 open-market purchases and 4 sales; 39 institutions reported holding it in 13F filings for Q3 2026, worth $7.84M in total; no superinvestor holds it.
Key figures
- Market capClose on Nov 19, 2026
- $13.6M
- Insider buysOpen market, last 90 days
- 0
- Insider sellsLast 90 days, $794.88 in total
- 4
- 13F holdersQ3 2026, +5 vs. previous quarter
- 39
- 13F valueReported value at the end of Q3 2026
- $7.84M
- Superinvestors holdingAt the end of Q3 2026
- 0
Price chart
Financials
See financial statementsFrom SEC filings, in USD.
- Revenue, FY2025
- $789.0K
- No comparable prior period
- Net income, FY2025
- $5.70M
- +4,088.2% year over year
- Free cash flow, FY2025
- $865.0K
- No comparable prior period
- Revenue, Q3 FY2026
- $593.0K
- +68.9% year over year
Revenue flow, FY2025
Green is profit; orange is costs, expenses and taxes. Percentages are shares of revenue.
Net income for FY2025: $5.70M (721.9% of revenue).
Short interest
See short dataFrom FINRA, settlement date Oct 30, 2026.
- Short interest
- 342.2K
- Shares sold short
- Change
- +29.9K
- +9.6% vs. previous
- Days to cover
- 4.31
- At average daily volume
Superinvestors holding MCRB, Q3 2026
Go to the superinvestors tabNo superinvestor reported holding MCRB at the end of Q3 2026.
Latest insider trades
See all insider tradesOpen-market purchases and sales by Seres Therapeutics, Inc. insiders from Form 4, newest first.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Nov 17, 2026 (view filing)4:15 PM ET | Nov 16 | 1 day | Brady KellySee Remarks | SSale | −85 | $1.38 | −$117.3 | −1.0%8.78K after | 10b5-1 |
| Nov 17, 2026 (view filing)4:15 PM ET | Nov 16 | 1 day | DesRosier ThomasSee Remarks | SSale | −103 | $1.38 | −$142.14 | −1.2%8.26K after | 10b5-1 |
| Nov 17, 2026 (view filing)4:15 PM ET | Nov 16 | 1 day | Shaff Eric D.Director | SSale | −287 | $1.38 | −$396.06 | −2.2%12.9K after | 10b5-1 |
| Nov 17, 2026 (view filing)4:15 PM ET | Nov 16 | 1 day | Henn Matthew R.See Remarks | SSale | −101 | $1.38 | −$139.38 | −1.2%8.13K after | 10b5-1 |
| Aug 18, 2026 (view filing)5:33 PM ET | Aug 17 | 1 day | Brady KellySee Remarks | SSale | −64 | $4.55 | −$291.2 | −0.7%8.68K after | 10b5-1 |
| Aug 18, 2026 (view filing)5:27 PM ET | Aug 17 | 1 day | Shaff Eric D.Director | SSale | −263 | $4.55 | −$1.20K | −2.1%12.5K after | 10b5-1 |
| Aug 18, 2026 (view filing)5:25 PM ET | Aug 17 | 1 day | Henn Matthew R.See Remarks | SSale | −81 | $4.55 | −$368.55 | −1.0%8.00K after | 10b5-1 |
| Aug 18, 2026 (view filing)5:22 PM ET | Aug 17 | 1 day | DesRosier ThomasSee Remarks | SSale | −82 | $4.55 | −$373.1 | −1.0%8.12K after | 10b5-1 |
| May 19, 2026 (view filing) | May 18 | 1 day | Shaff Eric D.Director | SSale | −259 | $7.53 | −$1.95K | −2.1%12.0K after | 10b5-1 |
| May 19, 2026 (view filing) | May 18 | 1 day | Brady KellySee Remarks | SSale | −59 | $7.53 | −$444.27 | −0.7%8.56K after |
Top 10 13F holders, Q3 2026
See all 39 holdersThe largest institutional positions in Seres Therapeutics, Inc. at the end of Q3 2026; share changes are against Q2 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Flagship Pioneering Inc. | 1,155,850 | $3.87M | 0.20% | 00.0% | Unchanged |
| Vanguard Capital Management LLC | 286,405 | $959.5K | 0.00% | −1,371−0.5% | Reduced |
| Marshall Wace, LLP | 139,278 | $466.6K | 0.00% | −32,967−19.1% | Reduced |
| Jacobs Levy Equity Management, Inc | 134,375 | $450.2K | 0.00% | +134,375 | New |
| Vontobel Holding Ltd. | 114,566 | $383.8K | 0.00% | −8,409−6.8% | Reduced |
| BlackRock, Inc. | 109,827 | $367.9K | 0.00% | −1,173−1.1% | Reduced |
| Geode Capital Management, LLC | 78,898 | $264.4K | 0.00% | −1,076−1.3% | Reduced |
| Susquehanna International Group, LLP | 62,692 | $210.0K | 0.00% | +4,364+7.5% | Added |
| Vanguard Fiduciary Trust Co | 48,685 | $163.1K | 0.00% | 00.0% | Unchanged |
| State Street Corp | 33,901 | $113.6K | 0.00% | 00.0% | Unchanged |